Literature DB >> 1354504

Enzymatic and chemical demethylenation of (methylenedioxy)amphetamine and (methylenedioxy)methamphetamine by rat brain microsomes.

L Y Lin1, Y Kumagai, A K Cho.   

Abstract

The metabolism of (methylenedioxy)amphetamine (MDA) and (methylenedioxy)methamphetamine (MDMA) was examined in microsomal preparations from rat brains. The products generated from MDA and MDMA were identified as dihydroxyamphetamine (DHA) and dihydroxymethamphetamine (DHMA), respectively. The demethylenation reaction required NADPH and was strongly inhibited by CO/O2 (4:1 v/v), suggesting that the formation of DHA and DHMA is mediated by cytochrome P450. The conversion was inhibited by desipramine, imipramine, and methimazole, whereas SKF-525A and alpha-naphthoflavone had little effect. Lineweaver-Burk plots of MDA and MDMA demethylenation were biphasic in both cases, indicating that multiple isozymes may participate in the oxidation. The microsomal preparation showed no significant stereoselectivity in the demethylenation of either MDA or MDMA. Catechol formation differed with the incubation buffer and was 2.6 times greater when phosphate rather than HEPES buffer was used. This difference disappeared, however, when desferrioxamine B methanesulfonate (desferal) and hydroxyl radical (.OH) scavenging agents were added to either buffer. The demethylenation was also sensitive to catalase and was stimulated by the addition of ferric ion and EDTA to the microsomal incubation mixture. These results indicate that the demethylenation of MDA and MDMA by rat brain microsomes has a cytochrome P450-mediated component as well as a chemical component involving .OH.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1354504     DOI: 10.1021/tx00027a013

Source DB:  PubMed          Journal:  Chem Res Toxicol        ISSN: 0893-228X            Impact factor:   3.739


  11 in total

Review 1.  Drug-metabolizing cytochrome P450s in the brain.

Authors:  Sharon L Miksys; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2002-11       Impact factor: 6.186

2.  Brain drug-metabolizing cytochrome P450 enzymes are active in vivo, demonstrated by mechanism-based enzyme inhibition.

Authors:  Sharon Miksys; Rachel F Tyndale
Journal:  Neuropsychopharmacology       Date:  2008-07-30       Impact factor: 7.853

3.  Increased oxidative-modifications of cytosolic proteins in 3,4-methylenedioxymethamphetamine (MDMA, ecstasy)-exposed rat liver.

Authors:  Vijay V Upreti; Kwan-Hoon Moon; Li-Rong Yu; Insong J Lee; Natalie D Eddington; Xiaoying Ye; Timothy D Veenstra; Byoung-Joon Song
Journal:  Proteomics       Date:  2010-12-15       Impact factor: 3.984

4.  Effect of methamphetamine on the pharmacokinetics of dextromethorphan and midazolam in rats.

Authors:  M Dostalek; E Hadasova; M Hanesova; J Pistovcakova; A Sulcova; J Jurica; J Tomandl; I Linhart
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

5.  Proceedings of the British Pharmacological Society. Clinical Pharmacology Section. 14-16 April 1993. Abstracts.

Authors: 
Journal:  Br J Clin Pharmacol       Date:  1993-08       Impact factor: 4.335

Review 6.  Acute and long-term effects of MDMA on cerebral dopamine biochemistry and function.

Authors:  M Isabel Colado; Esther O'Shea; A Richard Green
Journal:  Psychopharmacology (Berl)       Date:  2004-04-09       Impact factor: 4.530

Review 7.  Clinical pharmacokinetics of amfetamine and related substances: monitoring in conventional and non-conventional matrices.

Authors:  Rafael de la Torre; Magí Farré; Mónica Navarro; Roberta Pacifici; Piergiorgio Zuccaro; Simona Pichini
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype.

Authors:  M I Colado; J L Williams; A R Green
Journal:  Br J Pharmacol       Date:  1995-08       Impact factor: 8.739

9.  Dioxygenases catalyze O-demethylation and O,O-demethylenation with widespread roles in benzylisoquinoline alkaloid metabolism in opium poppy.

Authors:  Scott C Farrow; Peter J Facchini
Journal:  J Biol Chem       Date:  2013-08-08       Impact factor: 5.157

10.  Chronic nicotine treatment induces rat CYP2D in the brain but not in the liver: an investigation of induction and time course.

Authors:  Jiang Yue; Sharon Miksys; Ewa Hoffmann; Rachel F Tyndale
Journal:  J Psychiatry Neurosci       Date:  2008-01       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.